ENTITY
China Biologic Products

China Biologic Products (CBPO US)

27
Analysis
Health CareUnited States
China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.
more
Refresh
07 Jul 2020 14:10

Sina Corp: Management Buyout Offer

Sina Corp (Class A) (SINA US) looks sets to join the growing list of Chinese companies seeking to delist in the US and relist, ostensibly in Hong...

Logo
529 Views
Share
30 Apr 2020 10:28

(Mostly) Asia M&A: April 2020 Roundup

For the month of April, just six new deals were discussed on Smartkarma with an overall announced deal size of ~US$9.4bn. Clicking on the...

Logo
535 Views
Share
11 Mar 2020 20:32

China Biologic Products Privatisation: Share Price Gains from a Potential Deal Seem Priced In

It was reported by Bloomberg and several other news media outlets that a Chinese buyout group is in advanced talks to take China Biologic Products...

Share
bullishLY
29 Nov 2019 13:02

(Mostly) Asia M&A: November 2019 Roundup

For the month of November, 21 new deals were discussed on Smartkarma with an overall announced deal size of ~US$75bn, helped in large part by...

Logo
580 Views
Share
07 Nov 2019 14:59

CITIC Envirotech's Privatisation Offer

Back on the 12 November 2014, CITIC Environment and KKR China Water jointly announced a pre-conditional Offer for  United Envirotech Ltd (as Citic...

Logo
549 Views
Share
x